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Case report
A 30-month-old Caucasian child presented with a 2-week history of eye rubbing and distress. No previous problems were reported. The lashes at the lateral end of the right upper lid were inverted ( Figure 1 ). The lid was easily everted by lateral traction. His parents were instructed to reposition the lid. Unfortunately, the lateral entropion quickly recurred and a week later he was no better. His parents were very keen to avoid any surgery. Examination under anaesthetic was unremarkable; there was no foreign body or conjunctival scarring. The lid was repositioned and a single injection of 10 U of Dysport Botulinum toxin was given into the lateral part of the pretarsal orbicularis oculi ( Figure 2) .
The entropion resolved. He has been followed-up for 15 months with only very, very occasional recurrence and that was managed with traction only.
Comment
Both congenital and acquired entropion occur in children. Orbicularis oculi muscle hypertrophy, orbicularis spasm, epiblepharon, and disinsertion of the lower lid retractors are suggested aetiologies of congenital entropion. 1 Acquired entropion is attributed to ocular infection, scarring, previous surgery, and trauma. 2 Upper lid entropion in children is rare. An Asian study reported successful surgical repair of upper lid entropion in 11 children. 3 Christiansen et al 4 reported Figure 1 Right eye upper lid entropion.
Correspondence Eye a case of congenital lower lid entropion in a 3-week old baby that responded to 5 U injection of Botulinum toxin, although the type of Botulium toxin was not stated.
In our case the upper lid entropion did not recur after the Botulinum toxin worn off. We suggest two possible mechanisms, either the cycle of orbicularis spasm due to irritation from the entropion was broken by the treatment or that facial growth changed the balance of the inverting effect of the orbicularis over the stability of the posterior lamellae. Children with epiblepharon commonly improve as the midface grows during childhood. 5 To our knowledge this is the first reported case of acquired lateral upper lid entropion in a child treated with Botulinum toxin. We suggest that this treatment could be used in children with entropion, where there is no obvious underlying cause.
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Case report
A 5-year-old boy presented to paediatric OPD with complaint of progressively diminishing distant vision since 2 years of age. He had normal general physical and systemic examination. Ocular movements and light and accommodation reflexes were bilaterally normal. For fundus examination, he was advised to instill 1% cyclopentolate eyedrops, two drops in each eye, three times at 15 min intervals. However, the father inadvertently instilled it five to six times over 2 h. After another 1 h, he reported again to our OPD with altered behaviour, visual hallucinations, and difficulty in walking. He was disoriented, with ataxic gait and slurred speech. Pupils were widely dilated and fixed (effect of cyclopentolate). Rest of the examination was unremarkable.
Based on these findings and their temporal relation to overdose of cyclopentolate eyedrops, a diagnosis of cyclopentolate toxicity was made. His symptoms gradually resolved over the next 6-8 h. He was discharged after 24 h of observation.
Comment
Cyclopentolate is a synthetic anticholinergic agent and causes rapid-onset cycloplegia. 1 Onset is within 30-60 min and effects last up to a day. 2 Cyclopentolate eyedrops pass readily through nasolacrimal duct and are well absorbed locally as well as systemically through conjunctiva and nasal mucosa. Systemic absorption also occurs through oropharynx, digestive system, and skin. 3, 4 There have been various reports of systemic toxicity following topical application of cyclopentolate eyedrops. [3] [4] [5] [6] [7] Children are especially prone due to lower body weight. Various manifestations in children include flushing, tachycardia, feeding intolerance, seizures, and drowsiness. Behavioural changes and transient psychotic reactions may also occur. 7 Physostigmine is the antidote of choice as it readily crosses the blood-brain barrier. Commonly used anticholinesterases such as neostigmine, pyridostigmine, and edrophonium do not cross the 
